174 related articles for article (PubMed ID: 20227329)
1. Head and neck in situ carcinoma: survival analysis of the Thuringian cancer registration database.
Guntinas-Lichius O; Wendt T; Buentzel J; Esser D; Lochner P; Mueller A; Schultze-Mosgau S; Altendorf-Hofmann A;
Oral Oncol; 2010 Apr; 46(4):e5-9. PubMed ID: 20227329
[TBL] [Abstract][Full Text] [Related]
2. Trends in epidemiology and treatment and outcome for head and neck cancer: a population-based long-term analysis from 1996 to 2011 of the Thuringian cancer registry.
Guntinas-Lichius O; Wendt TG; Kornetzky N; Buentzel J; Esser D; Böger D; Müller A; Schultze-Mosgau S; Schlattmann P; Schmalenberg H
Oral Oncol; 2014 Dec; 50(12):1157-64. PubMed ID: 25459063
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
4. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery.
Wong LY; Wei WI; Lam LK; Yuen AP
Head Neck; 2003 Nov; 25(11):953-9. PubMed ID: 14603456
[TBL] [Abstract][Full Text] [Related]
5. Time to first relapse as an outcome and a predictor of survival in patients with squamous cell carcinoma of the head and neck.
Hall SF; Groome PA; Rothwell D
Laryngoscope; 2000 Dec; 110(12):2041-6. PubMed ID: 11129017
[TBL] [Abstract][Full Text] [Related]
6. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
7. Improved survival in patients with Stage III-IV Head and neck cancer treated with radiotherapy as primary local treatment modality.
Rusthoven KE; Raben D; Chen C
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):343-50. PubMed ID: 18374508
[TBL] [Abstract][Full Text] [Related]
8. Neck dissection for squamous cell carcinoma of the head and neck.
Santa Maria PL; Sader C; Preston NJ; Fisher PH
Otolaryngol Head Neck Surg; 2007 Apr; 136(4 Suppl):S41-5. PubMed ID: 17398340
[TBL] [Abstract][Full Text] [Related]
9. Ten-year retrospective study of head and neck carcinoma in situ: incidence, treatment, and clinical outcome.
Christensen A; Kristensen E; Therkildsen MH; Specht L; Reibel J; Homøe P
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):174-8. PubMed ID: 23643320
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
Smith VA; Camp ER; Lentsch EJ
Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
[TBL] [Abstract][Full Text] [Related]
11. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible?
Gleich LL; Ryzenman J; Gluckman JL; Wilson KM; Barrett WL; Redmond KP
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):35-8. PubMed ID: 14732765
[TBL] [Abstract][Full Text] [Related]
12. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of head and neck cancer with retinoids: a negative result.
Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
Dietl B; Marienhagen J; Schäfer C; Kölbl O
Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
[TBL] [Abstract][Full Text] [Related]
15. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
16. [Identification of clinical, biological and prognostic factors in recurring squamous cell carcinoma of the head and neck].
De Stefani A; Magnano M; Bussi M; Cravero L; Lerda W; Usai A; Cavalot A; Ragona R; Gabriele P; Valente G; Cortesina G
Acta Otorhinolaryngol Ital; 1997 Jun; 17(3):219-24. PubMed ID: 9489148
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
18. Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database.
Guntinas-Lichius O; Wendt T; Buentzel J; Esser D; Lochner P; Mueller A; Schultze-Mosgau S; Altendorf-Hofmann A
J Cancer Res Clin Oncol; 2010 Jan; 136(1):55-63. PubMed ID: 19568769
[TBL] [Abstract][Full Text] [Related]
19. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
